HRP20040479B1 - Vaginalno ordinirani anti-aritmički agensi za tretiranje zdjelične boli i neplodnosti - Google Patents

Vaginalno ordinirani anti-aritmički agensi za tretiranje zdjelične boli i neplodnosti

Info

Publication number
HRP20040479B1
HRP20040479B1 HR20040479A HRP20040479A HRP20040479B1 HR P20040479 B1 HRP20040479 B1 HR P20040479B1 HR 20040479 A HR20040479 A HR 20040479A HR P20040479 A HRP20040479 A HR P20040479A HR P20040479 B1 HRP20040479 B1 HR P20040479B1
Authority
HR
Croatia
Prior art keywords
infertility
pelvic pain
administered anti
treating pelvic
vaginally administered
Prior art date
Application number
HR20040479A
Other languages
English (en)
Inventor
L. Levine Howard
J. Bologna William
De Ziegler Dominique
Original Assignee
Columbia Laboratories (Bermuda) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories (Bermuda) Limited filed Critical Columbia Laboratories (Bermuda) Limited
Publication of HRP20040479A2 publication Critical patent/HRP20040479A2/hr
Publication of HRP20040479B1 publication Critical patent/HRP20040479B1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Upotreba lidokaina i farmaceutski prihvatljivog bioadhezivnog nosača koji oslobađa ljekoviti agens u produženom vremenskom razdoblju poslije davanja,naznačena time što se koristi za proizvodnju medikamenta za vaginalno ordiniranje za smanjenje ili ublažavanje aritmije maternice, a gdje je lidokainprisutan u koncentraciji od 5 mas.% do 12.5 mas.%. Patent sadrži još 5 patentnih zahtjeva.
HR20040479A 2001-10-29 2004-05-27 Vaginalno ordinirani anti-aritmički agensi za tretiranje zdjelične boli i neplodnosti HRP20040479B1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33068401P 2001-10-29 2001-10-29
US10/278,912 US20030114394A1 (en) 2001-10-29 2002-10-24 Vaginally administered anti-dysrhythmic agents for treating pelvic pain
PCT/EP2002/012042 WO2003037381A1 (en) 2001-10-29 2002-10-28 Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility

Publications (2)

Publication Number Publication Date
HRP20040479A2 HRP20040479A2 (en) 2004-10-31
HRP20040479B1 true HRP20040479B1 (hr) 2009-02-28

Family

ID=26959337

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040479A HRP20040479B1 (hr) 2001-10-29 2004-05-27 Vaginalno ordinirani anti-aritmički agensi za tretiranje zdjelične boli i neplodnosti

Country Status (34)

Country Link
US (1) US20030114394A1 (hr)
EP (2) EP1764111B1 (hr)
JP (2) JP2005511564A (hr)
KR (2) KR20100088718A (hr)
CN (1) CN100404072C (hr)
AR (1) AR037048A1 (hr)
AT (2) ATE346614T1 (hr)
AU (1) AU2002350644B2 (hr)
BR (1) BR0213585A (hr)
CA (1) CA2465132C (hr)
CY (2) CY1106000T1 (hr)
DE (2) DE60234725D1 (hr)
DK (2) DK1764111T3 (hr)
ES (2) ES2275928T3 (hr)
GE (1) GEP20094614B (hr)
HK (2) HK1063293A1 (hr)
HR (1) HRP20040479B1 (hr)
HU (1) HUP0402389A3 (hr)
IL (3) IL161513A0 (hr)
MA (1) MA26230A1 (hr)
ME (1) ME00255B (hr)
MX (1) MXPA04003976A (hr)
MY (2) MY149482A (hr)
NO (1) NO333544B1 (hr)
NZ (1) NZ532295A (hr)
PE (1) PE20030692A1 (hr)
PL (2) PL369790A1 (hr)
PT (2) PT1764111E (hr)
RS (1) RS51414B (hr)
RU (2) RU2476212C2 (hr)
SI (2) SI1764111T1 (hr)
UA (1) UA90077C2 (hr)
WO (1) WO2003037381A1 (hr)
ZA (1) ZA200402944B (hr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341737B2 (en) * 1997-06-11 2008-03-11 Kimberly-Clark Worldwide, Inc. Medicated tampon
US7344732B2 (en) * 2002-01-10 2008-03-18 Kimberly-Clark Worldwide, Inc. Medicated tampon
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
US7744556B2 (en) 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7993667B2 (en) 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7919453B2 (en) 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US7708726B2 (en) 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
US20070253994A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
WO2008042228A2 (en) * 2006-09-28 2008-04-10 Med Institute, Inc. Medical devices incorporating a bioactive and methods of preparing such devices
US20080082038A1 (en) * 2006-09-28 2008-04-03 Vance Products Incorporated, D/B/A/ Cook Urological Incorporated Medical Device including a Bioactive in a Non-ionic and an Ionic Form and Methods of Preparation Thereof
EP2068958B1 (en) * 2006-09-28 2016-10-19 Cook Medical Technologies LLC Medical device including an anesthetic and method of preparation thereof
EP3470055A1 (en) * 2007-06-26 2019-04-17 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
US8940315B2 (en) * 2008-04-18 2015-01-27 Medtronic, Inc. Benzodiazepine formulation in a polyorthoester carrier
US8956642B2 (en) * 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
MX2010011880A (es) * 2008-04-29 2011-05-25 Pharnext Nuevos enfoques terapeuticos para tratar la enfermedad del alzheimer y trastornos relacionados mediante una modulacion de la respuesta de estres celular.
BRPI0803568B8 (pt) * 2008-08-14 2021-05-25 Biolab San Us Farm Ltda composição mucoaderente
RU2538674C2 (ru) * 2012-09-10 2015-01-10 Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") Фармацевтическая композиция, обладающая пролонгированной противоаритмической активностью
WO2015051336A1 (en) 2013-10-03 2015-04-09 David Wise Compositions and methods for treating pelvic pain and other conditions
JP6654057B2 (ja) * 2016-02-10 2020-02-26 国立大学法人 筑波大学 局所麻酔薬を含有するポリイオンコンプレックスを有効成分とする局所疼痛制御用組成物
WO2017165707A1 (en) * 2016-03-24 2017-09-28 Juniper Pharmaceuticals, Inc. Vaginal administration of agents for treating and preventing pain associated with gynecological medical procedures
BR102018008324A2 (pt) * 2018-04-25 2019-11-05 Laboratorios Ferring Ltda composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615697A (en) * 1983-11-14 1986-10-07 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
WO1991006290A1 (en) * 1989-11-03 1991-05-16 Riker Laboratories, Inc. Bioadhesive composition and patch
WO1995007699A1 (en) * 1993-09-15 1995-03-23 Columbia Laboratories, Inc. Novel method of progesterone delivery and affect thereof
WO1996010989A1 (en) * 1994-10-07 1996-04-18 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
WO1998056323A1 (en) * 1997-06-11 1998-12-17 Umd, Inc. Device and method for treatment of dysmenorrhea
WO1999013862A2 (en) * 1997-09-12 1999-03-25 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
WO1999015210A2 (en) * 1997-09-26 1999-04-01 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
WO2000010536A1 (en) * 1998-08-25 2000-03-02 Columbia Laboratories (Bermuda) Limited Extended release buccal bioadhesive tablet

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3387419A (en) * 1965-10-22 1968-06-11 Kamberg Henry Decking with trim strip
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5387419A (en) * 1988-03-31 1995-02-07 The University Of Michigan System for controlled release of antiarrhythmic agents
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5700485A (en) * 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
US5663492A (en) * 1996-06-05 1997-09-02 Alapati; Rama Rao System for continuous analysis and modification of characteristics of a liquid hydrocarbon stream
US5985861A (en) * 1996-11-04 1999-11-16 Columbia Laboratories, Inc. Progesterone for treating or reducing ischemia
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US5977143A (en) * 1997-02-15 1999-11-02 Edelstam; Greta Medicament against infertility which reduces phagocytosis of spermatozoa in women
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
CA2207227A1 (en) * 1997-06-09 1998-12-09 Johnson & Johnson Inc. Plant seed germination mat
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US6135153A (en) * 1998-01-02 2000-10-24 Cleland, Sr. John Anesthesia delivery systems and methods
CA2331844A1 (en) * 1998-05-07 1999-11-11 University Of Maryland, Baltimore A method for diagnosing and treating chronic pelvic pain syndrome
US6207696B1 (en) * 1998-09-15 2001-03-27 Cytos Pharamaceuticals, Llc Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine
US6486207B2 (en) * 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
EP1212051A4 (en) * 1999-08-27 2004-03-31 Merck & Co Inc METHOD FOR TREATING OR PREVENTING CHEMICAL PROSTATITIS OR CHRONIC POOL PAIN
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615697A (en) * 1983-11-14 1986-10-07 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
WO1991006290A1 (en) * 1989-11-03 1991-05-16 Riker Laboratories, Inc. Bioadhesive composition and patch
WO1995007699A1 (en) * 1993-09-15 1995-03-23 Columbia Laboratories, Inc. Novel method of progesterone delivery and affect thereof
WO1996010989A1 (en) * 1994-10-07 1996-04-18 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
WO1998056323A1 (en) * 1997-06-11 1998-12-17 Umd, Inc. Device and method for treatment of dysmenorrhea
WO1999013862A2 (en) * 1997-09-12 1999-03-25 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
WO1999015210A2 (en) * 1997-09-26 1999-04-01 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
WO2000010536A1 (en) * 1998-08-25 2000-03-02 Columbia Laboratories (Bermuda) Limited Extended release buccal bioadhesive tablet

Also Published As

Publication number Publication date
AR037048A1 (es) 2004-10-20
AU2002350644B2 (en) 2008-05-08
BR0213585A (pt) 2004-08-24
GEP20094614B (en) 2009-02-25
DK1764111T3 (da) 2010-04-06
WO2003037381A1 (en) 2003-05-08
EP1764111B1 (en) 2009-12-09
RU2008133235A (ru) 2010-02-20
HK1063293A1 (en) 2004-12-24
NO333544B1 (no) 2013-07-08
KR20050040820A (ko) 2005-05-03
CN1578675A (zh) 2005-02-09
DE60216495D1 (de) 2007-01-11
HK1102221A1 (en) 2007-11-09
ES2336238T3 (es) 2010-04-09
IL211288A (en) 2014-02-27
KR20100088718A (ko) 2010-08-10
IL211288A0 (en) 2011-04-28
US20030114394A1 (en) 2003-06-19
JP2011201909A (ja) 2011-10-13
NZ532295A (en) 2006-12-22
SI1441770T1 (sl) 2007-02-28
ME00255B (me) 2011-05-10
PT1441770E (pt) 2007-01-31
CA2465132A1 (en) 2003-05-08
PL369790A1 (en) 2005-05-02
DE60216495T2 (de) 2007-07-26
NO20042208L (no) 2004-07-29
CN100404072C (zh) 2008-07-23
JP2005511564A (ja) 2005-04-28
SI1764111T1 (sl) 2010-04-30
PE20030692A1 (es) 2003-08-28
EP1441770A1 (en) 2004-08-04
CY1106000T1 (el) 2011-04-06
PT1764111E (pt) 2010-01-29
RS36704A (en) 2006-10-27
MXPA04003976A (es) 2004-07-08
MA26230A1 (fr) 2004-07-01
HRP20040479A2 (en) 2004-10-31
HUP0402389A2 (hu) 2005-03-29
ATE451123T1 (de) 2009-12-15
CY1110288T1 (el) 2015-01-14
DK1441770T3 (da) 2007-03-19
ZA200402944B (en) 2005-03-30
UA90077C2 (uk) 2010-04-12
PL402549A1 (pl) 2013-08-05
RS51414B (en) 2011-02-28
MY145215A (en) 2012-01-13
RU2345758C2 (ru) 2009-02-10
CA2465132C (en) 2012-04-24
MEP34908A (en) 2011-02-10
ES2275928T3 (es) 2007-06-16
IL161513A (en) 2011-12-29
HUP0402389A3 (en) 2012-09-28
RU2476212C2 (ru) 2013-02-27
RU2004116346A (ru) 2005-03-10
MY149482A (en) 2013-08-30
IL161513A0 (en) 2004-09-27
EP1441770B1 (en) 2006-11-29
ATE346614T1 (de) 2006-12-15
DE60234725D1 (de) 2010-01-21
EP1764111A1 (en) 2007-03-21

Similar Documents

Publication Publication Date Title
HRP20040479B1 (hr) Vaginalno ordinirani anti-aritmički agensi za tretiranje zdjelične boli i neplodnosti
TNSN06036A1 (en) Pyridyl derivatives and their use as therapeutic agents
NZ545130A (en) Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
ATE504288T1 (de) Oros-push-stick für die kontrollierte abgabe von wirkstoffen
TNSN06032A1 (en) Pyridazine derivatives and their use as therapeutic agents
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
TNSN06034A1 (en) Pyridazine derivatives and their use as therapeutic agents
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
MY129356A (en) Electrospun pharmaceutical compositions
DK1173178T3 (da) Præparat, der omfatter apomorfin og sildenafil, og anvendelse deraf til behandling af erektil dysfunktion
ATE432689T1 (de) Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid
EA200400007A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ
ES2125324T3 (es) Film para suministro local de un farmaco para un tratamiento periodontal.
IL132853A (en) Composition for modulating the human sexual response
RS51154B (sr) Farmaceutske kompozicije koje sadrže niske koncentracije peroksida za lečenje i sprečavanje vaginalnih infekcija
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
HRP20020258B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
AR047948A1 (es) Formulaciuones de inhibidores de la fosfodiesterasa v
HRPK20040328B3 (en) Pharmaceutical composition comprising gamma-butyrobetaine
RU2001131730A (ru) Применение антипрогестогенов в комбинированной терапии
CA2431519A1 (en) Topical composition and method for treating urinary stress incontinence
PT1691805E (pt) Utilização de ácido urocânico capaz de acidificar o citoplasma celular e para prevenir ou interromper a proliferação celular numa pessoa
UA41100A (uk) Вагінальний супозиторій для лікування запальних захворювань піхви та вульви
CO5580799A2 (es) Agentes anti-disritmicos administrados vaginalmente para tratar el dolor pelvico e infertilidad

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20150904

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20161028